预测降尿酸治疗期间痛风频繁发作的临床模型建立与评价
Establishment and Evaluation of a Clinical Model to Predict Frequent Gout Attacks during Urate-Lowering Therapy
DOI: 10.12677/acm.2024.1451628, PDF,   
作者: 周 睿:青岛大学附属医院,山东 青岛
关键词: 痛风痛风急性发作预测模型Gout Flares Predict Model
摘要: 目的:确定降尿酸治疗过程中影响痛风患者痛风频繁发作风险的因素。方法:本研究为单中心、观察性研究,纳入2022年8月至2023年8月在青岛大学附属医院痛风门诊初诊且确诊为痛风的患者165名。入组后,所有患者开始降尿酸治疗(ULT),并在3个月、6个月、12个月时接受随访。在12个月内出现至少2次急性发作的患者(频繁痛风发作患者)与小于两次急性发作的患者(非频繁痛风发作患者)进行比较,计算痛风发作风险的比值比(ORs)。利用多因素logistic回归建立临床预测模型,并绘制受试者工作曲线(ROC)评价模型预测性能。结果:111名患者被归类为频繁痛风发作患者,54名患者被归类为非频繁痛风发作患者。痛风频繁发作患者的血沉、肉眼痛风石、痛风家族史较非频繁发作患者显著增高(P < 0.05)。两组患者在是否患有高血压、是否患有脂肪肝、年龄、尿酸和饮酒史方面差异无统计学意义(P > 0.05)。结论:本研究建立的预测痛风频繁发作预测模型的预测效能较好,为临床及时识别频繁痛风发作患者提供了一个参考工具。
Abstract: Objective: To determine the factors that affect the risk of frequent gout attacks in gout patients during uric acid-lowering treatment. Methods: This study is a single-center, observational study, including 165 patients who were first diagnosed with gout at the Gout Clinic of the Affiliated Hospital of Qingdao University from August 2022 to August 2023. After enrollment, all patients started urate-lowering therapy (ULT) and were followed up at 3 months, 6 months, and 12 months. Odds ratios (ORs) were calculated for the risk of gout attacks in patients who had at least two exacerbations within 12 months (frequent gout attack patients) compared with those who had less than two exacerbations (infrequent gout attack patients). Multi-factor logistic regression was used to establish a clinical prediction model, and a receiver operating curve (ROC) was drawn to evaluate the prediction performance of the model. Results: 111 patients were classified as having frequent gout attacks, and 54 patients were classified as having infrequent gout attacks in remission. The erythrocyte sedimentation rate, gross tophi, and family history of gout in patients with frequent gout attacks were significantly higher than those in the non-frequent attack group (P < 0.05). There was no statistically significant difference between the two groups in terms of whether they had hypertension, fatty liver, age, uric acid and drinking history (P > 0.05). Conclusion: The prediction model established in this study for predicting frequent gout attacks has good prediction performance and provides a reference tool for clinical timely identification of patients with frequent gout attacks.
文章引用:周睿. 预测降尿酸治疗期间痛风频繁发作的临床模型建立与评价[J]. 临床医学进展, 2024, 14(5): 1865-1870. https://doi.org/10.12677/acm.2024.1451628

参考文献

[1] Dalbeth, N., Choi, H.K., Joosten, L., et al. (2019) Gout. Nature Reviews Disease Primers, 5, Article No. 69. [Google Scholar] [CrossRef] [PubMed]
[2] Neogi, T., Jansen, T.L., Dalbeth, N., et al. (2015) Gout Classification Criteria: An American College of Rheumatology/ European League against Rheumatism Collaborative Initiative. Annals of the Rheumatic Diseases, 74, 1789-1798. [Google Scholar] [CrossRef] [PubMed]
[3] Richette, P., Doherty, M., Pascual, E., et al. (2017) 2016 Updated EULAR Evidence-Based Recommendations for the Management of Gout. Annals of the Rheumatic Diseases, 76, 29-42. [Google Scholar] [CrossRef] [PubMed]
[4] Pascart, T. and Lioté, F. (2019) Gout: State of the Art after a Decade of Developments. Rheumatology (Oxford), 58, 27-44. [Google Scholar] [CrossRef] [PubMed]
[5] Abhishek, A., Valdes, A.M., Zhang, W. and Doherty, M. (2016) Association of Serum Uric Acid and Disease Duration with Frequent Gout Attacks: A Case-Control Study. Arthritis Care & Research (Hoboken), 68, 1573-1577. [Google Scholar] [CrossRef] [PubMed]
[6] Khanna, D., Fitzgerald, J.D., Khanna, P.P., et al. (2012) American College of Rheumatology guidelines for Management of Gout. Part 1: Systematic Nonpharmacologic and Pharmacologic Therapeutic Approaches to Hyperuricemia. Arthritis Care & Research (Hoboken), 64, 1431-1446. [Google Scholar] [CrossRef] [PubMed]
[7] Hui, M., Carr, A., Cameron, S., et al. (2017) The British Society for Rheumatology Guideline for the Management of Gout. Rheumatology (Oxford), 56, 1246. [Google Scholar] [CrossRef] [PubMed]
[8] Becker, M.A., Schumacher Jr., H.R., Wortmann, R.L., et al. (2005) Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout. The New England Journal of Medicine, 353, 2450-2461. [Google Scholar] [CrossRef
[9] Dalbeth, N., Saag, K.G., Palmer, W.E., et al. (2017) Effects of Febuxostat in Early Gout: A Randomized, Double-Blind, Placebo-Controlled Study. Arthritis & Rheumatology, 69, 2386-2395. [Google Scholar] [CrossRef] [PubMed]
[10] Borstad, G.C., Bryant, L.R., Abel, M.P., Scroggie, D.A., Harris, M.D. and Alloway, J.A. (2004) Colchicine for Prophylaxis of Acute Flares When Initiating Allopurinol for Chronic Gouty Arthritis. The Journal of Rheumatology, 31, 2429-2432.
[11] Latourte, A., Bardin, T. and Richette, P. (2014) Prophylaxis for Acute Gout Flares after Initiation of Urate-Lowering Therapy. Rheumatology (Oxford), 53, 1920-1926. [Google Scholar] [CrossRef] [PubMed]
[12] Taylor, W.J., Schumacher Jr., H.R., Baraf, H.S., et al. (2008) A Modified Delphi Exercise to Determine the Extent of Consensus with OMERACT Outcome Domains for Studies of Acute and Chronic Gout. Annals of the Rheumatic Diseases, 67, 888-891. [Google Scholar] [CrossRef] [PubMed]
[13] Desai, J., Steiger, S. and Anders, H.J. (2017) Molecular Pathophysiology of Gout. Trends in Molecular Medicine, 23, 756-768. [Google Scholar] [CrossRef] [PubMed]
[14] Rose, D.M. and Liu-Bryan, R. (2006) Innate Immunity in Triggering and Resolution of Acute Gouty Inflammation. Current Rheumatology Reports, 8, 209-214. [Google Scholar] [CrossRef] [PubMed]
[15] Chen, J., Wu, M., Yang, J., Wang, J., Qiao, Y. and Li, X. (2017) The Immunological Basis in the Pathogenesis of Gout. Iranian Journal of Immunology, 14, 90-98.
[16] Pascart, T., Grandjean, A., Capon, B., et al. (2018) Monosodium Urate Burden Assessed with Dual-Energy Computed Tomography Predicts the Risk of Flares in Gout: A 12-Month Observational Study: MSU Burden and Risk of Gout Flare. Arthritis Research & Therapy, 20, Article No. 210. [Google Scholar] [CrossRef] [PubMed]
[17] Li, Y., Merriman, T.R., Chen, H., et al. (2024) Clinical Characteristics of Adolescent-Onset Gout in Chinese: A Hospital-Based Cross-Sectional Study. Seminars in Arthritis and Rheumatism, 65, 152405. [Google Scholar] [CrossRef] [PubMed]
[18] Wen, W., Lei, P., Dang, W., Ma, L., Hu, J. and Liu, J. (2024) Association between Family History in Patients with Primary Gout and Left Ventricular Diastolic Function: A Cross-Sectional Study. International Journal of General Medicine, 17, 1311-1322. [Google Scholar] [CrossRef